Regenxbio (RGNX) Other financing activities (2015 - 2021)

Regenxbio (RGNX) recorded quarterly Other financing activities of $128000.0 in Q2 2021, down 49.0% quarter-over-quarter from $251000.0 in Q1 2021.

Regenxbio (RGNX) Other financing activities (2015 - 2021) Analysis & Trends

Regenxbio's Other financing activities history runs 4 years deep, the most recent figure standing at $128000.0 for Q2 2021.

In Q2 2021, Other financing activities changed N/A year-over-year to $128000.0; the TTM figure through Dec 2021 stood at $379000.0 (changed N/A YoY), while the FY2021 annual figure was $379000.0, changed N/A from the prior year.
Other financing activities was $128000.0 for Q2 2021 at Regenxbio, down from $251000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $251000.0 in Q1 2021 to a low of $84000.0 in Q1 2017.
Historically, Other financing activities has averaged $163500.0 across 3 years, with a median of $146000.0 in 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	Regenxbio	315.11 Mn	85.04 Mn	-

Download Data